Herbal Works

Ancient Wisdom for Modern Wellness: Invest in the Evolution of Hemp and CBD.

Bridging nature and science to deliver high-purity botanical formulas designed for the entire family—pets included. A unique investment opportunity in a comprehensive health ecosystem.

Schedule Private Meeting

Select your preferred date and time to book a strategic briefing with our IR team.

Dual-Growth Strategy

Strategically targeting two of the highest-growth consumer verticals: Human Wellness & Performance and the High-Loyalty Pet Care Market.

Strict Federal Compliance

Hemp-derived formulas in full accordance with the 2018 Farm Bill, containing no more than 0.3% Delta-9 THC and enforced by strict 21+ age verification.

Scalable D2C Logistics

Optimized Direct-to-Consumer fulfillment architecture ensuring high-margin distribution, rapid delivery to permitted jurisdictions, and robust customer retention.

ESG & Social Impact

Building long-term brand equity through our Cosmos Cares initiative, donating a portion of profits to assist the homeless and their pets.

Market Dynamics

Capitalizing on a $39B Global Botanical Expansion

An institutional opportunity driven by consumer migration toward preventative wellness, rigorous clinical compliance, and high-margin recurring verticals.

Total Addressable Market
$39.0B
Global Projected TAM

Estimated global market valuation for verified botanical therapeutics by 2030.

Growth Trajectory
11.2%
Projected CAGR

Sustained compound annual growth rate accelerated by mainstream retail integration.

Portfolio Synergy
68%
Cross-Market Capture

High-loyalty customer overlap between premium human performance and pet care verticals.

Institutional Risk Mitigation

Regulatory Rigor & Full Federal Compliance

Engineered for institutional security. Herbal Works operates strictly within established legal frameworks, ensuring fully traceable, lab-verified product portfolios.

Federal Legal Framework

U.S. Farm Bill Compliant & Audited

All broad-spectrum formulations strictly contain under 0.3% Delta-9 THC on a dry-weight basis. This guarantees legal commercial distribution, seamless cross-border logistics, and complete bankability for institutional investors.

THC Threshold Standard < 0.3% Delta-9 THC
Commercial Jurisdiction 50 U.S. States & International
Institutional Audit Status Fully Verified / Active

Third-Party ISO Lab Testing

Every single batch undergoes testing by independent ISO-17025 accredited laboratories. Certificates of Analysis (COA) verify exact cannabinoid profiles guaranteeing zero heavy metals or pesticides.

Premium Quality Assurance

From raw botanical extraction to final packaging, all human and pet care products are processed following strict quality control protocols to ensure purity, consistency, and premium market standards.

An Executive Board Built to Scale

Backed by Experienced Operational Leadership

Herbal Works' success is backed by a board of directors that strategically combines top-tier talent from the entertainment industry, mass operations, and finance.

Wayne Howey - President & CEO
President & CEO

Wayne Howey

Greta Gaines - Co-Founder & Ambassador
Co-Founder, Singer-Songwriter & Ambassador

Greta Gaines

Amy Kromer - CFO & Secretary Treasurer
CFO & Secretary Treasurer

Amy Kromer

Nia Stiff - COO
Chief Operating Officer

Nia Stiff

Robert Kane - Investor Relations
Head of Investor Relations

Robert Kane

Investor Relations

Schedule a Private Strategic Briefing

Connect directly with our Capital Relations team to discuss growth milestones, investment terms, and strategic alignment for the current funding round.

Investor Relations Desk

Corporate Capital Schedule

888-74-HERBAL / IR Direct Line
Confidential Executive Review

Schedule Private Call

Complete the form below to book a direct 1-on-1 session with our IR team.